Skip to content

HSIC — Hedge Fund Holders & Catalysts | BiotechEdge

BiotechEdge New: AI Signals

Catalysts Convergence Squeeze Signals Cash Runway Insiders M&A Research

Sign In Start 14-Day Free Trial

Home›Companies›HENRY SCHEIN INC (HSIC)

HENRY SCHEIN INC

HSIC

Held by 2 specialist biotech funds

2 funds opened new positions. Short interest: 5.5% of float.

Share

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

3.0/10

2 funds opened new positions

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 2 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Deerfield Management

Eventide Asset Management

AI Signal

SIGNAL NOTE: DEERFIELD EXIT FROM HSIC

Deerfield Management's complete exit from Henry Schein (dental/medical distributor) reduces specialist fund ownership concentration; only Eventide Asset Management now holds the name among tracked specialist funds. This represents a divergence in conviction rather than a high-conviction signal, as single-fund holding lacks the convergence threshold typically associated with meaningful specialist positioning.

Unlock full AI analysis — 14-day free trial

2 quarters

Position Trend

Aug 14, 2025

$0

0 funds

Nov 14, 2025

$278K

1 fund

Feb 13, 2026

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 5 quarters

Short Interest

Short Shares

5.37M

Change

+12.5%

Days to Cover

3.3

% of Float

5.5%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

5 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

RVMD2 funds INSP2 funds TMDX2 funds CELC2 funds ARWR2 funds KYMR2 funds BBIO2 funds IONS2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: